Quality of Life and Meaning of Illness of Women With Lung Cancer
ABSTRACT To describe the quality of life (QOL) of women with non-small cell lung cancer (NSCLC) and examine relationships of demographic, clinical, health status, and meaning of illness (MOI) characteristics to QOL.
Descriptive, cross-sectional survey.
In-person interviews in homes or research offices.
217 women with NSCLC (greater than 6 months and less than 5 years since diagnosis, mean = 2 years); 19% of the women had advanced disease. The mean age was 65 years.
Assessments of QOL with cancer-specific (QOL Scale-Patient Version) and generic (Short Form-36) self-reports, health status (i.e., number and type of comorbid conditions, presence of depressed mood using the Center for Epidemiologic Studies Depression Scale, smoking status), and MOI (positive and negative perceptions).
QOL, health status, MOI, and demographic and clinical characteristics.
Serious disruptions in psychological and social aspects of QOL were common. Depressed mood, negative conceptualizations of MOI, and younger age explained 37% of the variance of global QOL and were correlated with poorer physical, psychological, and social dimensions of QOL. Thirty-six percent reported negative ascriptions of MOI; 35% experienced depressed mood; more than 75% reported distress with their diagnosis, family distress, and impact of sexual function as lowering their QOL; and 67% reported comorbid conditions, the most common being chronic obstructive pulmonary disease (31%).
Women with lung cancer experience a range of disruptions in QOL, and more than a third associate lung cancer with negative meaning. Younger age, depressed mood, and number of comorbid diseases are risk factors for negative QOL.
These findings support the importance of assessing the QOL, MOI, and health status of women with lung cancer even after treatment is completed. Younger women may be at higher risk for disruptions.
- SourceAvailable from: PubMed Central
[Show abstract] [Hide abstract]
- "For example, Mosack et al discuss a theme of “Restoration of Health” which holds the possibility of improvements in health, despite having HIV. Qualitative studies in samples with illnesses other than HIV report a significant proportion of participants in the “challenge” category [59,60] that may reflect a similar appraisal of the disease as a manageable chronic illness. "
ABSTRACT: Illness appraisals provide important context to help understand the way individuals cope with chronic illness. In the present study, a qualitative approach to the analysis of HIV diagnosis experience narratives in a sample of 100 people newly diagnosed with HIV revealed five groups that differed in their initial illness appraisals: HIV as Chronic Illness, Concern about Dying, Stigmatization, Threat to Identity, and Other Threats Overshadow HIV. When compared on quantitatively measured depressive mood, the groups differed on level and trajectory over the course of the first year post-diagnosis. Although the experience of living with HIV has changed significantly with the advent of effective Antiretroviral Therapies (ART), there were a number of similarities between the appraisals of this group of participants who were diagnosed post ART and groups who were diagnosed before ART became widely available. Posttest counselors and other HIV service providers should take individual differences in illness appraisals into account in order to help newly HIV-positive clients manage their healthcare and cope adaptively with their diagnosis.PLoS ONE 10/2013; 8(10):e78904. DOI:10.1371/journal.pone.0078904 · 3.23 Impact Factor
[Show abstract] [Hide abstract]
- "Depressed mood, younger age, and a negative approach to the nature of the disease were associated with deterioration of quality of life. Depression was experienced by 35% of women while distress due to diagnosis and affected family was experienced by more than 75% . Gilbert and colleagues noted that in patients with advanced cancer there also occurred anxiety, depression, social isolation and fear apart from symptoms from the respiratory system. "
ABSTRACT: Lung cancer accounts for 12% of all cancers and has the highest annual rate of mortality in men and women. The overall aim is cure or prolongation of life without evidence of disease. Almost 60% of patients at the moment of diagnosis are not eligible for radical treatment. Therefore soothing and supportive treatment is the only treatment of choice. Patients with lung cancer who have symptoms of dyspnea, chronic cough, severe pain, exhaustion and cachexia syndrome, fear and depression and significantly reduced physical and intellectual activities are qualified for inpatient or home palliative care. Knowledge about various methods used in palliative treatment allows one to alleviate symptoms that occur in an advanced stage of disease with an expected short survival period. Methods of oncological treatment that are often used in patients with advanced lung cancer include radiotherapy and chemotherapy. Drawing attention to the earlier implementation of palliative care is an objective of research carried out during recent years. Advances in surgical and conservative treatment of these patients have contributed to better outcomes and longer survival time.Contemporary Oncology / Wspólczesna Onkologia 06/2013; 17(3):238-245. DOI:10.5114/wo.2013.35033 · 0.22 Impact Factor
[Show abstract] [Hide abstract]
- "The possibility exists that this sample sought out an online support group because of depression. However, as a result of a lung cancer diagnosis, patients often experience increased psychological distress (Bottorff et al., 2009; Henoch et al., 2007; McBride et al., 2003; Sarna et al., Jan 2005). Because lung cancer patients experience more psychological distress than other cancer patients, stigma intervention and mood management needs to be an essential aspect of treatment. "
ABSTRACT: In 2010, lung cancer is expected to be the leading cause of cancer death in both men and women. Because survival rates are increasing, an evaluation of the effects of treatment on quality of life (QOL) is an important outcome measure. In other diseases, stigma is known to have a negative impact on health status and QOL and be amenable to intervention. This is the first study to compare levels of lung cancer stigma (LCS) and relationships between LCS, depression, and QOL in ever and never smokers. A total of 192 participants with a self-report diagnosis of lung cancer completed questionnaires online. Strong associations in the expected directions, were found between LCS and depression (r = 0.68, p < 0.001) and QOL (r = -0.65, p < 0.001). No significant differences were found in demographic characteristics or study variables between ever smokers and never smokers. A simultaneous multiple regression with 5 independent variables revealed an overall model that explained 62.5% of the total variance of QOL (F5,168 = 56.015, P < 0.001). After removing age, gender, and smoking status, depression explained 22.5% of the total variance of QOL (F4,168 = 100.661, p < 0.001). It is expected that depression and LCS would share some of the explanation of the variance of QOL, the correlation between LCS and depression is 0.629 (p < 0.001), however, LCS provides a unique and significant explanation of the variance of QOL over and above that of depression, age, gender, and smoking status, by 2.1% (p < 0.001).European journal of oncology nursing: the official journal of European Oncology Nursing Society 07/2011; 16(3):264-9. DOI:10.1016/j.ejon.2011.06.008 · 1.43 Impact Factor